Nuvalent Enters Material Definitive Agreement
Ticker: NUVL · Form: 8-K · Filed: Nov 20, 2025 · CIK: 1861560
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
Nuvalent just signed a big deal, filing an 8-K to let everyone know.
AI Summary
Nuvalent, Inc. announced on November 18, 2025, that it has entered into a material definitive agreement. The company, incorporated in Delaware with its principal executive offices in Cambridge, Massachusetts, filed this 8-K report to disclose this event. Further details regarding the agreement are expected to be provided.
Why It Matters
This filing indicates a significant new contract or partnership for Nuvalent, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks depending on the nature of the agreement, which is not fully detailed in this initial filing.
Key Numbers
- 001-40671 — SEC File Number (Identifies Nuvalent's filings with the SEC.)
- 81-5112298 — I.R.S. Employer Identification No. (Tax identification number for Nuvalent, Inc.)
Key Players & Entities
- Nuvalent, Inc. (company) — Registrant
- November 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Cambridge, Massachusetts (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Nuvalent, Inc.?
The filing states that Nuvalent, Inc. entered into a material definitive agreement on November 18, 2025, but the specific details of this agreement are not provided in this initial 8-K report.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on November 18, 2025.
What is Nuvalent, Inc.'s state of incorporation?
Nuvalent, Inc. is incorporated in Delaware.
Where are Nuvalent, Inc.'s principal executive offices located?
Nuvalent, Inc.'s principal executive offices are located at One Broadway, 14th Floor, Cambridge, Massachusetts 02142.
What is the SEC file number for Nuvalent, Inc.?
The SEC file number for Nuvalent, Inc. is 001-40671.
Filing Stats: 1,346 words · 5 min read · ~4 pages · Grade level 11.3 · Accepted 2025-11-20 06:01:19
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value per share NUVL The Nasdaq
- $101.00 — price to the public in the Offering is $101.00 per share, and the Underwriters have ag
- $95.445 — he Underwriting Agreement at a price of $95.445 per share. Under the terms of the Under
- $471.9 m — from the Offering will be approximately $471.9 million, after deducting underwriting dis
- $75 million — receive gross proceeds of approximately $75 million. The Company will not receive any proce
Filing Documents
- d33478d8k.htm (8-K) — 33KB
- d33478dex11.htm (EX-1.1) — 224KB
- d33478dex51.htm (EX-5.1) — 11KB
- d33478dex991.htm (EX-99.1) — 9KB
- g33478dsp1.jpg (GRAPHIC) — 4KB
- g33478dsp4.jpg (GRAPHIC) — 4KB
- g33478g1120023425512.jpg (GRAPHIC) — 2KB
- 0001193125-25-288770.txt ( ) — 474KB
- nuvl-20251118.xsd (EX-101.SCH) — 3KB
- nuvl-20251118_lab.xml (EX-101.LAB) — 18KB
- nuvl-20251118_pre.xml (EX-101.PRE) — 11KB
- d33478d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated November 18, 2025, by and among the Company, Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., J.P. Morgan Securities LLC, Jefferies LLC, TD Securities (USA) LLC and Cantor Fitzgerald & Co. 5.1 Opinion of Sidley Austin LLP. 23.1 Consent of Sidley Austin LLP (included in Exhibit 5.1). 99.1 Press Release issued by the Company on November 18, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Nuvalent, Inc. Date: November 20, 2025 By: /s/ Deborah Miller Deborah Miller, Ph.D. Chief Legal Officer and Secretary